Recently, disruption of ANGPTL2 in apolipoprotein E-deficient mice (ApoE-/-/Angptl2-/-) was found to attenuate atherosclerosis progression by decreasing the number of macrophage infiltrating atheromatous plaques, thereby reducing vascular inflammation [9]. This evidence concerns the gene ANGPTL2 and atherosclerosis.